Abstract
A methylene violet 3RAX-conjugated porphyrin has been designed and synthesized as a potential photosensitizer in photodynamic therapy because of its high DNA binding constant and the efficacy in inhibiting cancer cells with subcellular localization.
Cite
CITATION STYLE
APA
Yao, S., Zheng, Y., Jiang, L., Xie, C., Wu, F., Huang, C., … Wang, K. (2018). Methylene violet 3RAX-conjugated porphyrin for photodynamic therapy: Synthesis, DNA photocleavage, and cell study. RSC Advances, 8(8), 4472–4477. https://doi.org/10.1039/c7ra13176c
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free